First PREMIER Bank’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $645K | Sell |
538
-29
| -5% | -$29.6K | 0.1% | 111 |
|
|
2026
Q1 | $522K | Hold |
567
| – | – | 0.12% | 115 |
|
|
2025
Q4 | $610K | Hold |
567
| – | – | 0.14% | 103 |
|
|
2025
Q3 | $432K | Hold |
567
| – | – | 0.1% | 119 |
|
|
2025
Q2 | $443K | Buy |
567
+34
| +6% | +$26.4K | 0.11% | 117 |
|
|
2025
Q1 | $440K | Hold |
533
| – | – | 0.11% | 111 |
|
|
2024
Q4 | $412K | Hold |
533
| – | – | 0.1% | 115 |
|
|
2024
Q3 | $472K | Sell |
533
-28
| -5% | -$25.2K | 0.12% | 112 |
|
|
2024
Q2 | $508K | Buy |
561
+5
| +0.9% | +$4K | 0.14% | 104 |
|
|
2024
Q1 | $432K | Buy |
556
+23
| +4% | +$16.4K | 0.11% | 112 |
|
|
2023
Q4 | $311K | Buy |
533
+1
| +0.2% | +$584 | 0.09% | 126 |
|
|
2023
Q3 | $286K | Hold |
532
| – | – | 0.09% | 124 |
|
|
2023
Q2 | $249K | Sell |
532
-5
| -0.9% | -$2.1K | 0.07% | 140 |
|
|
2023
Q1 | $185K | Sell |
537
-90
| -14% | -$30.4K | 0.05% | 150 |
|
|
2022
Q4 | $230K | Buy |
627
+32
| +5% | +$11.3K | 0.07% | 137 |
|
|
2022
Q3 | $193K | Hold |
595
| – | – | 0.06% | 135 |
|
|
2022
Q2 | $193K | Hold |
595
| – | – | 0.06% | 144 |
|
|
2022
Q1 | $171K | Buy |
595
+150
| +34% | +$38.6K | 0.05% | 148 |
|
|
2021
Q4 | $123K | Hold |
445
| – | – | 0.03% | 172 |
|
|
2021
Q3 | $103K | Hold |
445
| – | – | 0.03% | 179 |
|
|
2021
Q2 | $102K | Buy |
+445
| New | +$89.4K | 0.03% | 177 |
|
|
2020
Q3 | – | Sell |
-100
| Closed | -$16K | – | 332 |
|
|
2020
Q2 | $16K | Sell |
100
-50
| -33% | -$7.67K | 0.01% | 247 |
|
|
2020
Q1 | $21K | Hold |
150
| – | – | 0.01% | 206 |
|
|
2019
Q4 | $20K | Hold |
150
| – | – | 0.01% | 222 |
|
|
2019
Q3 | $17K | Buy |
+150
| New | +$16.7K | 0.01% | 225 |
|
|
2019
Q2 | – | Sell |
-80
| Closed | -$10K | – | 290 |
|
|
2019
Q1 | $10K | Hold |
80
| – | – | 0.01% | 244 |
|
|
2018
Q4 | $9K | Buy |
+80
| New | +$8.94K | 0.01% | 244 |
|
|
2018
Q3 | – | Sell |
-85
| Closed | -$7K | – | 273 |
|
|
2018
Q2 | $7K | Hold |
85
| – | – | ﹤0.01% | 214 |
|
|
2018
Q1 | $7K | Hold |
85
| – | – | 0.01% | 214 |
|
|
2017
Q4 | $7K | Hold |
85
| – | – | ﹤0.01% | 217 |
|
|
2017
Q3 | $7K | Hold |
85
| – | – | ﹤0.01% | 225 |
|
|
2017
Q2 | $7K | Hold |
85
| – | – | 0.01% | 211 |
|
|
2017
Q1 | $7K | Hold |
85
| – | – | 0.01% | 200 |
|
|
2016
Q4 | $6K | Hold |
85
| – | – | ﹤0.01% | 200 |
|
|
2016
Q3 | $7K | Buy |
+85
| New | +$6.8K | 0.01% | 219 |
|
Other funds holding LLY
First PREMIER Bank's LLY Position: Q2 2026 in Review
First PREMIER Bank reduced its Eli Lilly (LLY) stake by 5.1% in Q2 2026, selling an estimated $29.6K and leaving 538 shares worth $645K. The position accounts for 0.1% of the portfolio, ranked #111.
First PREMIER Bank first reported a position in LLY in Q3 2016 and has held it in 35 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- First PREMIER Bank held 538 shares of Eli Lilly worth $645K as of Q2 2026.
- First PREMIER Bank sold 29 Eli Lilly shares in Q2 2026, an estimated $29.6K.
- Eli Lilly made up 0.1% of First PREMIER Bank's portfolio in Q2 2026, its #111 holding.
- First PREMIER Bank first reported a position in Eli Lilly in Q3 2016 and has held it in 35 quarters since.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on First PREMIER Bank's 13F filing for Q2 2026, filed 15 Jul 2026.